Urinary Microbiome

Abstract

The urinary system is thought to be sterile for many years, has come to an end with recent studies that may actually have a flora like intestines and skin. As a result of studies on the presence of microbiota in the urinary system, it is questioned whether probiotics and prebiotics can be used in the treatment of some urological diseases. In this review we aimed to evaluate the relations between urinary microbiome and the diseases. 

Keywords

• probiotics
• prebiotics
• urinary microbiome

Üriner Mikrobiyota

Abstract

Uzun yıllardan beri steril kabul edilen üriner sistemin yapılan çalışmalarda aslında bağırsaklar ve cilt gibi bir floraya sahip olabileceği gündeme gelmiştir. Üriner sistem mikrobiyotasının varlığı üzerine yapılan çalışmalar sonucunda bazı ürolojik hastalıkların tedavisinde probiyotiklerin ve prebiyotiklerin kullanılıp kullanılamayacağı sorgulanmaktadır. Biz bu derlememizde üriner mikrobiyota ve hastalıklarla olan ilişkilerini derlemeyi amaçladık. 

Keywords

• Probiyotik
• üriner mikrobiyom

References

1. 1. Aragón IM, Herrera-Imbroda B, Queipo-Ortuño MI, Cas- tillo E, Del Moral JS, Gómez-Millán J, Yucel G, Lara MF. The Urinary Tract Microbiome in Health and Disease. Eur Urol Focus. 2016 Nov 14. pii: S2405-4569(16)30159-6.
2. 2. Karakan T, Tahtaci M, Alagozlu H. Probiotics: should we be more definitive in terminology? Eur J Gastroenterol Hepatol 2012;24:1115-6.
3. 3. Alfano M, Canducci F, Nebuloni M, Clementi M, Montorsi F, Salonia A. The interplay of extracellular matrix and microbiome in urothelial bladder cancer. Nat Rev Urol 2016;13:77-90.
4. 4. Aagaard K, Ma J, Antony KM, Ganu R, Petrosino J, Ver- salovic J. The placenta harbors a unique microbiome. Sci Transl Med. 2014 May 21;6(237):237ra65.
5. 5. Branton WG, Ellestad KK, Maingat F, Wheatley BM, Rud E, Warren RL, Holt RA, Surette MG, Power C. Brain mic- robial populations in HIV/AIDS: α-proteobacteria pre- dominate independent of host immune status. PLoS One. 2013;8(1):e54673.
6. 6. Thomas-White K, Brady M, Wolfe AJ, Mueller ER. The bladder is not sterile: History and current discoveries on the urinary microbiome. Curr Bladder Dysfunct Rep 2016;11:18-24.
7. 7. Karakan T, Ergun M, Dogan I, Cindoruk M, Unal S. Com- parison of early enteral nutrition in severe acute pancreatitis with prebiotic fiber supplementation versus standard enteral solution: a prospective randomized double-blind study. World J Gastroenterol. 2007 May 21;13(19):2733-7.
8. 8. NIH HMP Working Group, Peterson J, Garges S, Giovan- ni M, McInnes P, Wang L, Schloss JA, Bonazzi V, McE- wen JE, Wetterstrand KA, Deal C, Baker CC, Di Frances- co V, Howcroft TK, Karp RW, Lunsford RD, Wellington CR, Belachew T, Wright M, Giblin C, David H, Mills M, Salomon R, Mullins C, Akolkar B, Begg L, Davis C, Gran- dison L, Humble M, Khalsa J, Little AR, Peavy H, Pontzer C, Portnoy M, Sayre MH, Starke-Reed P, Zakhari S, Read J, Watson B, Guyer M. The NIH Human Microbiome Project. Genome Res 2009;19:2317-23.

9. 9. Lewis DA, Brown R, Williams J, White P, Jacobson SK, Marchesi JR, Drake MJ. The human urinary microbiome; bacterial DNA in voided urine of asymptomatic adults. Front Cell Infect Microbiol. 2013 Aug 15;3:41.
10. 10. Hilt EE, McKinley K, Pearce MM, Rosenfeld AB, Zilliox MJ, Mueller ER, Brubaker L, Gai X, Wolfe AJ, Schrecken- berger PC. Urine is not sterile: use of enhanced urine cultu- re techniques to detect resident bacterial flora in the adult female bladder. J Clin Microbiol 2014;52:871-6.
11. 11. Pearce MM, Zilliox MJ, Rosenfeld AB, Thomas-White KJ, Richter HE, Nager CW, Visco AG, Nygaard IE, Barber MD, Schaffer J, Moalli P, Sung VW, Smith AL, Rogers R, Nolen TL, Wallace D, Meikle SF, Gai X, Wolfe AJ, Brubaker L; Pelvic Floor Disorders Network. The female urinary micro- biome in urgency urinary incontinence. Am J Obstet Gyne- col 2015 Sep;213(3):347.e1-11.
12. 12. Siddiqui H, Nederbragt AJ, Lagesen K, Jeansson SL, Jakob- sen KS. Assessing diversity of the female urine microbiota by high throughput sequencing of 16S rDNA amplicons. BMC Microbiol 2011 Nov 2;11:244.
13. 13. Fouts DE, Pieper R, Szpakowski S, Pohl H, Knoblach S, Suh MJ, Huang ST, Ljungberg I, Sprague BM, Lucas SK, Tor- ralba M, Nelson KE, Groah SL. Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacte- riuria in neuropathic bladder associated with spinal cord injury. J Transl Med 2012 Aug 28;10:174.
14. 14. Nelson DE, Dong Q, Van der Pol B, Toh E, Fan B, Katz BP, Mi D, Rong R, Weinstock GM, Sodergren E, Fortenberry JD. Bacterial communities of the coronal sulcus and distal urethra of adolescent males. PLoS One 2012;7:e36298.
15. 15. Brubaker L, Wolfe AJ. The new world of the urinary microbiota in women. Am J Obstet Gynecol 2015;213:644-9.
16. 16. Horwitz D, et al. Decreased microbiota diversity associated with urinary tract infection in a trial of bacterial interference. J Inf Secur 2015;71:358–67.
17. 17. Trautner BW, Hull RA, Darouiche RO. Colicins prevent colonization of urinary catheters. J Antimicrob Chemother 2005;56:413-5.
18. 18. Darouiche RO, Thornby JI, Cerra-Stewart C, Donovan WH, Hull RA. Bacterial interference for prevention of uri- nary tract infection: a prospective, randomized, placebo- controlled, double-blind pilot trial. Clin Infect Dis 2005 Nov 15;41:1531-4.
19. 19. Cadieux PA, Burton J, Devillard E, Reid G. Lactobacillus by-products inhibit the growth and virulence of uropathogenic Escherichia coli. J Physiol Pharmacol 2009 Dec;60 Suppl 6:13-8.
20. 20. Chapman CM, Gibson GR, Rowland I. Effects of single- and multi-strain probiotics on biofilm formation and in vitro adhesion to bladder cells by urinary tract pathogens. Anaerobe 2014;27:71-6.
21. 21. Chromek M, Slamová Z, Bergman P, Kovács L, Podracká L, Ehrén I, Hökfelt T, Gudmundsson GH, Gallo RL, Ager- berth B, Brauner A. The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infecti- on. Nat Med 2006 Jun;12:636-41.
22. 22. Morrison G, Kilanowski F, Davidson D, Dorin J. Characte- rization of the Mouse beta defensin 1, Defb1, mutant mouse model. Infect Immun. 2002 Jun;70(6):3053-60.
23. 23. Groah SL, Pérez-Losada M, Caldovic L, Ljungberg IH, Sprague BM, Castro-Nallar E, Chandel NJ, Hsieh MH, Pohl HG. Redefining Healthy Urine: A Cross-Sectional Exploratory Metagenomic Study of People With and Without Bladder Dysfunction. J Urol 2016 Aug;196:579-87.
24. 24. Trautner BW, Hull RA, Thornby JI, Darouiche RO. Coating urinary catheters with an avirulent strain of Escherichia coli as a means to establish asymptomatic colonization. Infect Control Hosp Epidemiol. 2007 Jan;28:92-4.
25. 25. Darouiche RO, Green BG, Donovan WH, Chen D, Schwartz M, Merritt J, Mendez M, Hull RA. Multicenter randomized controlled trial of bacterial interference for prevention of urinary tract infection in patients with neurogenic bladder. Urology. 2011 Aug;7:341-6.
26. 26. Guay DR. Cranberry and urinary tract infections. Drugs 2009;69:775-807.
27. 27. Foxman B, Cronenwett AE, Spino C, Berger MB, Morgan DM. Cranberry juice capsules and urinary tract infection after surgery: results of a randomized trial. Am J Obstet Gynecol. 2015 Aug;213:194.e1-8.
28. 28. Domenici L, Monti M, Bracchi C, Giorgini M, Colagiovan- ni V, Muzii L, Benedetti Panici P. D-mannose: a promising support for acute urinary tract infections in women. A pilot study. Eur Rev Med Pharmacol Sci 2016 Jul;20:2920-5.
29. 29. Hashim H, Abrams P. Is the bladder a reliable witness for predicting detrusor overactivity? J Urol 2006 Jan;175:191-4; discussion 194-5.
30. 30. Sorrentino F, Cartwright R, Digesu GA, Tolton L, Franklin L, Singh A, Greco P, Khullar V. Associations between in- dividual lower urinary tract symptoms and bacteriuria in random urine samples in women. Neurourol Urodyn 2015 Jun;34:429-33.
31. 31. Karstens L, Asquith M, Davin S, Stauffer P, Fair D, Gre- gory WT, Rosenbaum JT, McWeeney SK, Nardos R. Does the Urinary Microbiome Play a Role in Urgency Urinary Incontinence and Its Severity? Front Cell Infect Microbiol 2016 Jul 27;6:78.
32. 32. Thomas-White KJ, Hilt EE, Fok C, Pearce MM, Mueller ER, Kliethermes S, Jacobs K, Zilliox MJ, Brincat C, Price TK, Kuffel G, Schreckenberger P, Gai X, Brubaker L, Wolfe AJ. Incontinence medication response relates to the female urinary microbiota. Int Urogynecol J 2016 May;27:723-33.
33. 33. Broomfield RJ, Morgan SD, Khan A, Stickler DJ. Crystalli- ne bacterial biofilm formation on urinary catheters by ure- ase-producing urinary tract pathogens: a simple method of control. J Med Microbiol 2009 Oct;58(Pt 10):1367-75.
34. 34. Wang X, Krambeck AE, Williams JC Jr, Tang X, Rule AD, Zhao F, Bergstralh E, Haskic Z, Edeh S, Holmes DR 3rd, Herrera Hernandez LP, Lieske JC. Distinguishing charac- teristics of idiopathic calcium oxalate kidney stone formers with low amounts of Randall’s plaque. Clin J Am Soc Neph- rol 2014 Oct 7;9:1757-63.
35. 35. Tavichakorntrakool R, Prasongwattana V, Sungkeeree S, Saisud P, Sribenjalux P, Pimratana C, Bovornpadungkitti S, Sriboonlue P, Thongboonkerd V. Extensive characteri- zations of bacteria isolated from catheterized urine and sto- ne matrices in patients with nephrolithiasis. Nephrol Dial Transplant. 2012 Nov;27:4125-30.
36. 36. Barr-Beare E, Saxena V, Hilt EE, Thomas-White K, Schober M, Li B, Becknell B, Hains DS, Wolfe AJ, Schwaderer AL. The Interaction between Enterobacteriaceae and Calcium Oxalate Deposits. PLoS One 2015 Oct 8;10:e0139575.
37. 37. Knight J, Deora R, Assimos DG, Holmes RP. The genetic composition of Oxalobacter formigenes and its relationship to colonization and calcium oxalate stone disease. Urolithiasis 2013;41:187-96.
38. 38. Siener R, Bangen U, Sidhu H, Hönow R, von Unruh G, Hes- se A. The role of Oxalobacter formigenes colonization in calcium oxalate stone disease. Kidney Int 2013;83:1144-9.
39. 39. Siener R, Bangen U, Sidhu H, Hönow R, von Unruh G, Hes- se A. The role of Oxalobacter formigenes colonization in calcium oxalate stone disease. Kidney Int 2013;83:1144-9.
40. 40. Hatch M, Cornelius J, Allison M, Sidhu H, Peck A, Fre- el RW. Oxalobacter sp. reduces urinary oxalate excreti- on by promoting enteric oxalate secretion. Kidney Int 2006;69:691-8.
41. 41. Duncan SH, Richardson AJ, Kaul P, Holmes RP, Allison MJ, Stewart CS. Oxalobacter formigenes and its potential role in human health. Appl Environ Microbiol 2002;68:3841-7.
42. 42. Milliner D, Hoppe B, Groothoff J. A randomised Phase II/ III study to evaluate the efficacy and safety of orally admi- nistered Oxalobacter formigenes to treat primary hypero- xaluria. Urolithiasis 2017 Jul 17.
43. 43. Miller AW, Dale C, Dearing MD. The Induction of Oxalate Metabolism In Vivo Is More Effective with Functional Microbial Communities than with Functional Microbial Species. mSystems 2017 Sep 26;2(5).
44. 44. Mittal RD, Kumar R, Bid HK, Mittal B. Effect of antibiotics on Oxalobacter formigenes colonization of human gastrointestinal tract. J Endourol 2005;19:102-6.
45. 45. Lange JN, Wood KD, Wong H, Otto R, Mufarrij PW, Knight J, Akpinar H, Holmes RP, Assimos DG. Sensitivity of human strains of Oxalobacter formigenes to commonly prescribed antibiotics. Urology 2012;79:1286-9.
46. 46. Aso, Y. & Akazan, H. Prophylactic effect of a Lactobacillus case preparation on the recurrence of superficial bladder cancer. BLP Study Group. Urol. Int 1992;49:125-29.